{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-21-014614","form_type":"8-K","ticker":"PGNY","cik":"0001551306","company_name":"Progyny, Inc.","filed_at":"2021-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.993671+00:00","generated_at":"2026-06-28T12:56:49.551192+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Progyny Reports Q3 2021 Revenue of $122.3M, Appoints Pete Anevski as CEO","bullets":["Q3 2021 revenue $122.3M (+24% YoY), net income $16.8M vs $4.8M in prior year.","Added 85+ new clients for 2022, representing approximately 1.2M new covered lives.","David Schlanger to become Executive Chairman; Pete Anevski succeeds as CEO effective Jan 1, 2022.","Full-year 2021 revenue guidance raised to $507M-$514M, growth of 47-49%."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-21-014614","json":"https://secwatch.observer/filing/0001558370-21-014614.json","markdown":"https://secwatch.observer/filing/0001558370-21-014614.md","text":"https://secwatch.observer/filing/0001558370-21-014614.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/pgny-20211104x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T12:56:49.551192+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9c6b3a25e0","claim":"David Schlanger changed role as Executive Chairman at Progyny, Inc..","evidence_excerpt":"On November 4, 2021, Progyny, Inc. (the “Company”) announced that David Schlanger plans to transition to the role of Executive Chairman, effective as of January 1, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transition to"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"},{"claim_id":"a7eed2784a","claim":"Beth Seidenberg was appointed as Lead Independent Director at Progyny, Inc..","evidence_excerpt":"Beth Seidenberg, M.D., who currently serves as Chair of the Board, will assume the position of Lead Independent Director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"assume"},{"label":"Role","value":"Lead Independent Director"}],"fact_type":"executive_change"},{"claim_id":"b83fedd59f","claim":"Pete Anevski was appointed as Director at Progyny, Inc..","evidence_excerpt":"the Board has appointed Mr. Anevski as a director of the Company effective as of the date he becomes Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b881962239","claim":"Michael Sturmer changed role as President at Progyny, Inc..","evidence_excerpt":"Michael Sturmer, 45, who currently serves as Executive Vice President, Chief Growth and Strategy Officer, will succeed Mr. Anevski as President, effective as of January 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"succeed"},{"label":"Role","value":"President"}],"fact_type":"executive_change"},{"claim_id":"dc34c28898","claim":"Pete Anevski changed role as Chief Executive Officer at Progyny, Inc..","evidence_excerpt":"Pete Anevski, 54, who currently serves as President and Chief Operating Officer, will succeed Mr. Schlanger as Chief Executive Officer, effective as of January 1, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551306/000155837021014614/0001558370-21-014614-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"succeed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}